{
    "nctId": "NCT02102568",
    "briefTitle": "Impact of Chemo-induced Menopause on Quality of Life in Women <45 Years Old, Diagnosed With Non-metastatic Breast Cancer",
    "officialTitle": "Study of the Impact of Chemo-induced Menopause on the Quality of Life in Young Women of Childbearing Age and Diagnosed With Non-metastatic Breast Cancer",
    "overallStatus": "COMPLETED",
    "conditions": "BREAST CANCER",
    "studyType": "OBSERVATIONAL",
    "phase": "N/A",
    "allocation": "N/A",
    "primaryPurpose": "N/A",
    "enrollmentCount": 240,
    "primaryOutcomeMeasure": "Evaluation of the 2-year impact of chemo-induced menopause (CIM) on the functional score of the QLQ-C30 quality of life questionnaire in young women of childbearing age and diagnosed with breast cancer.",
    "eligibilityCriteria": "Inclusion Criteria:\n\n* Patient aged over 18 and under 45\n* Patient without amenorrhea at diagnosis\n* Performance status less than 2 (according to WHO criteria )\n* Patient diagnosed with histologically proven non-metastatic breast cancer\n* Clinical Stages I, IIA, IIB and IIIA\n* Positive Hormone Receptors (defined by a rate of 10% of labeled cells and immunohistochemistry (IHC) ) or negative\n* Positive or negative HER2 status ( defined a score of 0 or 1 + by IHC , or a 2 + score by IHC and FISH / ISHS / CISH negative)\n* Patients to be treated with neoadjuvant or adjuvant chemotherapy\n* Satisfying hematological, renal and hepatic functions : PNN\\> 2,109 / L, platelets \\> 100 . 109 / L, Hb\\> 10 g / dl , normal bilirubin, AST and ALT \\<2.5 upper normal value ( VNS) , alkaline phosphatase \\<2.5 VSN , creatinine clearance \\> 60 ml / min\n* Obtaining informed consent in writing, signed and dated\n* Affiliation to Social Security system (or being the beneficiary of such a plan) under the terms of the Act of August 9, 2004\n\nExclusion Criteria:\n\n* Male patient\n* Metastatic cancer\n* Any T4 tumor (skin invasion, deep grip, inflammatory breast cancer)\n* Patient who underwent surgical castration of ovariectomy or hysterectomy or tubal ligation\n* Patients with endometriosis\n* Pregnant or breastfeeding patients\n* Patients with no effective contraception\n* Patients who have had hormone therapy or chemotherapy\n* Patient who have already taken Gn-RH or LH-RH analogues (chemical castration)\n* Patient whose mother was in menopause early without treatment\n* Presence of comorbidities related to fertility or medical history related to ovarian failure or sterility\n* Significant neurological or psychiatric abnormalities\n* Inability of the patient to complete the questionnaires (the language barrier)\n* Patients deprived of liberty by court or administrative decision\n* Patient with another pathology deemed incompatible with the inclusion of the patient in the protocol\n* Participation in another clinical trial involving the chemical or surgical castration of the patient\n* Patients geographically unstable in the 6 months following inclusion or residing away from the treatment center and thereby making it difficult to monitor",
    "sex": "FEMALE",
    "minimumAge": "18 Years",
    "stdAges": "ADULT"
}